Retinoid X receptors in macrophage biology

Tamás Rőszer1, María P Menéndez-Gutiérrez, Marta Cedenilla

  • 1Cardiovascular Development and Repair Department, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029 Madrid, Spain.

Insights

Retinoid X receptors (RXRs) are nuclear receptors controlling gene expression in macrophages. Targeting RXR pathways offers potential treatments for inflammatory and metabolic diseases like atherosclerosis and insulin resistance.

Area of Science:

  • Molecular Biology
  • Endocrinology
  • Immunology

Background:

  • Retinoid X receptors (RXRs) are a unique subclass of nuclear receptors.
  • RXRs are ligand-dependent transcription factors regulating diverse biological processes.
  • Macrophages are crucial in inflammatory and metabolic disorders, and RXRs are key regulators of their function.

Purpose of the Study:

  • To review the versatile roles of RXRs in controlling macrophage gene transcription.
  • To highlight the mechanisms of RXR action, including heterodimerization and homodimerization.
  • To explore the therapeutic potential of RXR-targeted transcriptional programs for diseases involving macrophage dysfunction.

Main Methods:

  • Literature review of studies on Retinoid X receptors and macrophage biology.
  • Analysis of RXR heterodimerization and homodimerization in gene regulation.
  • Synthesis of current research on RXR targets in inflammatory and metabolic diseases.

Main Results:

  • RXRs exhibit versatile control over macrophage gene transcription.
  • Heterodimerization with other nuclear receptors and homodimerization are key mechanisms.
  • RXR-controlled pathways are implicated in atherosclerosis, insulin resistance, autoimmunity, and neurodegeneration.

Conclusions:

  • RXRs are critical regulators of macrophage function.
  • Targeting RXR transcriptional programs presents a promising therapeutic strategy for various pathologies.
  • Further research into RXR-mediated pathways can lead to novel treatments for inflammatory and metabolic diseases.